Sasaki, S. et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J. Virol. 81, 215–228 (2007).
Fiore, A.E. et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm. Rep. 59, 1–62 (2010).
Sasaki, S. et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS ONE 3, e2975 (2008).
Zeman, A.M. et al. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Pediatr. Infect. Dis. J. 26, 107–115 (2007).
Pulendran, B., Li, S. & Nakaya, H.I. Systems vaccinology. Immunity 33, 516–529 (2010).
Querec, T.D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116–125 (2009).
Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119–3131 (2008).
Pulendran, B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol. 9, 741–747 (2009).
Monath, T.P. Yellow fever vaccine. Expert Rev. Vaccines 4, 553–574 (2005).
Querec, T. et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413–424 (2006).
Barrett, A.D. & Teuwen, D.E. Yellow fever vaccine–how does it work and why do rare cases of serious adverse events take place? Curr. Opin. Immunol. 21, 308–313 (2009).
Johnson, P.R. Jr. Feldman, S., Thompson, J.M., Mahoney, J.D. & Wright, P.F. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J. Med. Virol. 17, 325–335 (1985).
Beyer, W.E., Palache, A.M., de Jong, J.C. & Osterhaus, A.D. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 20, 1340–1353 (2002).
US Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines (Office of Communication, Training and Manufacturers Assistance, Rockville, Maryland, 2007).
Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667–671 (2008).
Takaoka, A. & Yanai, H. Interferon signalling network in innate defence. Cell. Microbiol. 8, 907–922 (2006).
Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116–5121 (2001).
Iwakoshi, N.N. et al. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 4, 321–329 (2003).
Iwakoshi, N.N., Lee, A.H. & Glimcher, L.H. The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response. Immunol. Rev. 194, 29–38 (2003).
Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519–529 (2007).
Ueda, Y. et al. Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults. Hum. Immunol. 64, 1144–1151 (2003).
Shen-Orr, S.S. et al. Cell type-specific gene expression differences in complex tissues. Nat. Methods 7, 287–289 (2010).
Avery, D.T. et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112, 286–297 (2003).
Park, S.W. et al. The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nat. Med. 16, 429–437 (2010).
Liu, B. & Li, Z. Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin. Blood 112, 1223–1230 (2008).
Apostolou, A., Shen, Y., Liang, Y., Luo, J. & Fang, S. Armet, a UPR-upregulated protein, inhibits cell proliferation and ER stress-induced cell death. Exp. Cell Res. 314, 2454–2467 (2008).
Huleatt, J.W. et al. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26, 201–214 (2008).
Treanor, J.J. et al. Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine 28, 8268–8274 (2010).
Talbot, H.K. et al. Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin. PLoS ONE 5, e14442 (2010).
He, X.S. et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J. Virol. 80, 11756–11766 (2006).
Le Bon, A. et al. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176, 2074–2078 (2006).
Lee, E.K. Large-scale optimization-based classification models in medicine and biology. Ann. Biomed. Eng. 35, 1095–1109 (2007).
Brooks, J.P. & Lee, E.K. Analysis of the consistency of a mixed integer programming-based multi-category constrained discriminant model. Ann. Oper. Res. 174, 147–168 (2010).
Sullivan, S.J., Jacobson, R. & Poland, G.A. Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine. Expert Rev. Vaccines 9, 1127–1133 (2010).
Anderson, K.J. & Allen, R.L. Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells. Immunology 127, 8–17 (2009).
Thomas, R., Matthias, T. & Witte, T. Leukocyte immunoglobulin-like receptors as new players in autoimmunity. Clin. Rev. Allergy Immunol. 38, 159–162 (2010).
Brown, D., Trowsdale, J. & Allen, R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64, 215–225 (2004).
Krebs, J., Wilson, A. & Kisielow, P. Calmodulin-dependent protein kinase IV during T-cell development. Biochem. Biophys. Res. Commun. 241, 383–389 (1997).
Wang, S.L., Ribar, T.J. & Means, A.R. Expression of Ca2+/calmodulin-dependent protein kinase IV (caMKIV) messenger RNA during murine embryogenesis. Cell Growth Differ. 12, 351–361 (2001).
Anderson, K.A. & Means, A.R. Defective signaling in a subpopulation of CD4+ T cells in the absence of Ca2+/calmodulin-dependent protein kinase IV. Mol. Cell. Biol. 22, 23–29 (2002).
Illario, M. et al. Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells. Blood 111, 723–731 (2008).
Sato, K. et al. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 12, 1410–1416 (2006).
Kitsos, C.M. et al. Calmodulin-dependent protein kinase IV regulates hematopoietic stem cell maintenance. J. Biol. Chem. 280, 33101–33108 (2005).
Pulendran, B. & Ahmed, R. Immunological mechanisms of vaccination. Nat. Immunol. 131, 509–517 (2011).
Moldoveanu, Z., Clements, M.L., Prince, S.J., Murphy, B.R. & Mestecky, J. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 13, 1006–1012 (1995).
Shubinsky, G. & Schlesinger, M. The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. Immunity 7, 315–324 (1997).
Deaglio, S., Mehta, K. & Malavasi, F. Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk. Res. 25, 1–12 (2001).
Clements, M.L., Betts, R.F., Tierney, E.L. & Murphy, B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 24, 157–160 (1986).
Potter, C.W. & Oxford, J.S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 35, 69–75 (1979).
Hirota, Y. et al. Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. Vaccine 15, 962–967 (1997).
Belshe, R.B. Current status of live attenuated influenza virus vaccine in the US. Virus Res. 103, 177–185 (2004).
Chen, G.L., Lamirande, E.W., Jin, H., Kemble, G. & Subbarao, K. Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 398, 109–114 (2010).
Crotty, S. et al. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171, 4969–4973 (2003).
Wu, J.Y. et al. Spermiogenesis and exchange of basic nuclear proteins are impaired in male germ cells lacking Camk4. Nat. Genet. 25, 448–452 (2000).